HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Michael Hinz Michael Schmoeckel Hermann Reichenspurner Bruno Meiser Bruno Reichart Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brenner, P. Articles by Reichart, B. Search for Related Content PubMed PubMed Citation Articles by Brenner, P. Articles by Reichart, B.

Eur J Cardiothorac Surg 1999;15:672-679
© 1999 Elsevier Science NL

The influence of antibody and complement removal with a Ig-Therasorb column in a xenogeneic working heart model¹

^a Department of Cardiac Surgery, Klinikum Grosshadern, Ludwig–Maximilians-University Munich, Marchioninistr. 15, D-81377 Munich, Germany
^b Institute for Surgical Research, Klinikum Grosshadern, Ludwig–Maximilians-University Munich, Munich, Germany

Received 20 September 1998; received in revised form 23 December 1998; accepted 10 February 1999.

Corresponding author. Tel.: +49-89-7095-4404; fax: +49-89-7095-8897.

Objective: Organ transplantation is limited by the number of brain-dead human donors. Xenotransplantation could be an alternative to guarantee a constant supply of organs. A major problem of xenotransplantation are xenogeneic natural antibodies (XNAb) directed against species-specific antigens of a discordant donor species (e.g. pig). They trigger the hyperacute xenograft rejection (HXR). Re-usable immunoapheresis (IA)-columns Ig-Therasorb® (Therasorb, Baxter) were used to adsorb these XNAb. The effect of immunoapheresis of the perfusing human blood was investigated in ex vivo working pig hearts. Methods: Hearts of 12 landrace pigs (body weight 14–31 kg) were explanted after inducing cardiac arrest with 4°C Celsior solution. Human blood (500 ml, heparinized) was obtained from healthy volunteers. In group 1 (G1, n=6), blood as perfusate remained untreated. In group 2 (G2, n=6), native blood was separated by plasmapheresis into cellular components and plasma. The latter passed through the Ig-Therasorb column for removal of immunoglobulins (so-called immunoadsorption or immunoapheresis). After back-table preparation the hearts were mounted to the working heart model. After 20 min of reperfusion in Langendorff mode, the working heart mode was established. Blood samples were taken isochronously for measurement of: CK(-MB), LDH, ASAT, troponin, immunoglobulins, complement activity, anti-pig antibodies and others. After cessation of the heart, atrial and ventricular tissue samples were taken for histological examinations (light/electron microscopy and immunohistochemistry). Results: Two cycles of immunoapheresis reduced the levels of IgG by 84%, IgM by 83.3% and IgA by 76%. In G2, the antibody immunoadsorption of blood prolonged the duration of the working heart mode significantly to 335±37.5 min. In contrast, hearts of group 1 (control) failed after 125±31.3 min. Heart rate was significantly different between both groups (G1, 77.3±6.1 beats/min; G2, 86.5±5.5 beats/min). In G2 cardiac output was 118% and mean coronary flow was 154.6% higher than in G1. CK, LDH and ASAT showed no differences in the two groups. Heart weight increased significantly more in group 1 than in G2. Histological examination indicated specific signs of HXR in G1 after 1.5 h, whereas in G2 only slight unspecific damages were found after 6 h. Conclusion: Antibody removal by means of immunoapheresis results in a significantly improved xenogeneic cardiac function. Immunoapheresis may, therefore, become an important adjunct in future pig-to-man clinical xenotransplantation.

Key Words: Working heart perfusion • Xenotransplantation • Hyperacute rejection • Immunoadsorption • Ig Therasorb® column

This article has been cited by other articles:

				R. T. Smolenski, M. Forni, M. Maccherini, M. L. Bacci, E. M. Slominska, H. Wang, P. Fornasari, R. Giovannoni, F. Simeone, A. Zannoni, et al. Reduction of hyperacute rejection and protection of metabolism and function in hearts of human decay accelerating factor (hDAF)-expressing pigs Cardiovasc Res, January 1, 2007; 73(1): 143 - 152. [Abstract] [Full Text] [PDF]

				L. B. Becker, M. L. Weisfeldt, M. H. Weil, T. Budinger, J. Carrico, K. Kern, G. Nichol, I. Shechter, R. Traystman, C. Webb, et al. The PULSE Initiative: Scientific Priorities and Strategic Planning for Resuscitation Research and Life Saving Therapies Circulation, May 28, 2002; 105(21): 2562 - 2570. [Full Text] [PDF]

				S. Pfeiffer, G. L. Zorn III, S. Kelishadi, R. Oriol, P. Wolf, R. N. Pierson III, and A. M. Azimzadeh Role of anti-Gal{alpha}1,3Gal and anti-platelet antibodies in hyperacute rejection of pig lung by human blood Ann. Thorac. Surg., November 1, 2001; 72(5): 1681 - 1690. [Abstract] [Full Text] [PDF]